Expression of Pirh2, a newly identified ubiquitin protein ligase, in lung cancer

被引:76
作者
Duan, WR
Gao, L
Druhan, LJ
Zhu, WG
Morrison, C
Otterson, GA
Villalona-Calero, MA
机构
[1] Ohio State Univ, Coll Med & Publ Hlth, Ctr Comprehens Canc, Columbus, OH 43210 USA
[2] Ohio State Univ, Coll Med & Publ Hlth, Dept Internal Med, Columbus, OH 43210 USA
[3] Ohio State Univ, Coll Med & Publ Hlth, Dept Pathol, Columbus, OH 43210 USA
来源
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE | 2004年 / 96卷 / 22期
关键词
D O I
10.1093/jnci/djh292
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Maintenance of p53 function is important for normal cell growth and development, and loss of p53 function contributes directly to malignant tumor development. The recently discovered Pirh2 protein is an ubiquitin-protein ligase that negatively regulates p53 through activity by targeting it for degradation. To determine how Pirh2 may mediate lung tumorigenesis, we evaluated Pirh2 expression in human and mouse lung tumor samples and paired normal lung tissues using immunoblot analysis and immunohistochemistry. Pirh2 protein expression was higher in 27 (84%) of 32 human lung neoplasms than in matched normal lung tissue and in 14 of 15 mouse lung tumors evaluated. In addition, p53 protein was more ubiquitinated in the mouse lung tumors than in normal tissue, and overall p53 expression was lower than that in normal tissue. These results are consistent with the hypothesis that increased Pirh2 expression affects lung tumorigenesis by reducing p53 activity. To our knowledge, this is the first description of altered Pirh2 expression in human and mouse tumors.
引用
收藏
页码:1718 / 1721
页数:4
相关论文
共 27 条
[21]   A phase 2 study of bortezomib in relapsed, refractory myeloma [J].
Richardson, PG ;
Barlogie, B ;
Berenson, J ;
Singhal, S ;
Jagannath, S ;
Irwin, D ;
Rajkumar, SV ;
Srkalovic, G ;
Alsina, M ;
Alexanian, R ;
Siegel, D ;
Orlowski, RZ ;
Kuter, D ;
Limentani, SA ;
Lee, S ;
Hideshima, T ;
Esseltine, DL ;
Kauffman, M ;
Adams, J ;
Schenkein, DP ;
Anderson, KC .
NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (26) :2609-2617
[22]   Chalcone derivatives antagonize interactions between the human oncoprotein MDM2 and p53 [J].
Stoll, R ;
Renner, C ;
Hansen, S ;
Palme, S ;
Klein, C ;
Belling, A ;
Zeslawski, W ;
Kamionka, M ;
Rehm, T ;
Mühlhahn, P ;
Schumacher, R ;
Hesse, F ;
Kaluza, B ;
Voelter, W ;
Engh, RA ;
Holak, TA .
BIOCHEMISTRY, 2001, 40 (02) :336-344
[23]   Surfing the p53 network [J].
Vogelstein, B ;
Lane, D ;
Levine, AJ .
NATURE, 2000, 408 (6810) :307-310
[24]  
Voorhees PM, 2003, CLIN CANCER RES, V9, P6316
[25]   p53: Death star [J].
Vousden, KH .
CELL, 2000, 103 (05) :691-694
[26]   Stabilization of p53 by CP-31398 inhibits ubiquitination without altering phosphorylation at serine 15 or 20 or MDM2 binding [J].
Wang, WG ;
Takimoto, R ;
Rastinejad, F ;
El-Deiry, WS .
MOLECULAR AND CELLULAR BIOLOGY, 2003, 23 (06) :2171-2181
[27]   P21 IS A UNIVERSAL INHIBITOR OF CYCLIN KINASES [J].
XIONG, Y ;
HANNON, GJ ;
ZHANG, H ;
CASSO, D ;
KOBAYASHI, R ;
BEACH, D .
NATURE, 1993, 366 (6456) :701-704